SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-19-000146
Filing Date
2019-11-07
Accepted
2019-11-07 07:53:09
Documents
76
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q exicure10q93019.htm 10-Q 1298797
2 EXHIBIT 31.1 exicureexhibit311-93019.htm EX-31.1 7937
3 EXHIBIT 31.2 exicureexhibit312-93019.htm EX-31.2 7816
4 EXHIBIT 32.1 exicureexhibit321-93019.htm EX-32.1 9431
  Complete submission text file 0001698530-19-000146.txt   5002471

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xcur-20190930.xml EX-101.INS 832070
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20190930.xsd EX-101.SCH 42750
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20190930_cal.xml EX-101.CAL 73849
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20190930_def.xml EX-101.DEF 137726
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20190930_lab.xml EX-101.LAB 519781
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20190930_pre.xml EX-101.PRE 304395
Mailing Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077
Business Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 191198180
SIC: 2834 Pharmaceutical Preparations